Aurobindo Pharma gets 14 USFDA observations for Pashamylaram facility Farhat Nasim15 Nov 2019 6:43 AM GMTThe US Food and Drug Administration (USFDA) inspected company's Unit IV, a general injectable formulation manufacturing facility situated at...